FDAnews
www.fdanews.com/articles/132082-cephalon-loses-uk-bid-to-halt-mylan-generic-sales

Cephalon Loses UK Bid to Halt Mylan Generic Sales

November 19, 2010
Cephalon Inc., maker of the sleep-disorder drug Provigil, can’t block Mylan Inc. and Orchid Chemicals & Pharmaceuticals Ltd. from selling generic versions of the drug in Britain before a patent trial, a judge ruled.
Bloomberg Businessweek